Wellcome-MRC Institute of Metabolic Science
Including a brand new taught MPhil – Obesity, Endocrinology and Metabolism
About us
The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded Medical Research Council (MRC) Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease. We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
Training graduate students for a scientific career is a priority at the IMS-MRL. We have a mixture of both basic science students and clinical trainees and aim to provide everyone with a supportive, stimulating research and learning environment.
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Wellcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
COVID-19
We continue to follow Government and University of Cambridge guidelines for staying COVID-safe.
Equality, diversity, inclusion and wellbeing
We aspire to be a place where everyone feels welcome, included, safe and heard.
Videos
Skinny genes – the genetics behind body weight
Why does obesity make COVID-19 more dangerous?
Live from the lab – do you want to see what it’s like to work in our Institute? Four short films for young people
News
Upcoming Events
Professor Bettina Mittendorfer, Division of Geriatrics & Nutritional Science, Washington University, USA – “Obesity-related alterations in beta-cell function and heterogeneity of metabolic function in obesity and in response to weight loss”
October 10 @ 1:15 pm - 2:15 pmCore Facility Seminar
October 17 @ 1:15 pm - 2:15 pmPerry group – Dr Yajie Zhao – “Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease”
October 23 @ 1:15 pm - 2:15 pm
